> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Priority Zoonotic Animal Drugs
- URL: https://www.fdaweb.com/guide-on-priority-zoonotic-animal-drugs/
- Published: 2023-12-17T12:00:00.000Z
- Updated: 2026-09-14T14:18:45.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156009

FDA has released a [draft guidance](https://www.fda.gov/media/174635/download?ref=fdaweb.com) entitled “Priority Zoonotic Animal Drug (PZAD) Designation and Review Process.” FDA says that a PZAD is defined as a “new animal drug, that alone or in combination with one or more other animal drugs, has the potential to prevent or treat a zoonotic disease in animals, including a vector-borne disease, that has the potential to cause serious adverse health consequences for, or serious or life-threatening diseases in, humans.” The document covers the eligibility criteria for PZAD designations, the process for designation requests, and the process for expedited development and review of PZADs.